✦ LIBER ✦

Trioxifene mesylate in the treatment of advanced breast cancer

✍ Scribed by Raymond W. Lee; Aman U. Buzdar; George R. Blumenschein; Gabriel N. Hortobagyi

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 360 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860101)57:1<40::aid-cncr2820570110>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluoxymesterone in the treatment of adva

Fluoxymesterone in the treatment of advanced breast cancer

✍ B. J. Kennedy 📂 Article 📅 1957 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

Castration in the treatment of advanced

Castration in the treatment of advanced breast cancer

✍ Edward F. Lewison 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 1 views

Treatment of advanced male breast cancer

✍ William G. Kraybill; Richard Kaufman; David Kinne 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 1 views

The modalities used to treat 27 male patients with metastatic breast cancer at Memorial Hospital from 1957-1979 are reviewed. The overall objective orchiectomy response rate was 48% (11123). The median response was 11 months (6-96 months). The median survival in responders was 58 months, whereas the

Carminomycin.A new anthracycline analog

Carminomycin.A new anthracycline analog in the treatment of advanced breast cancer

✍ Ambrose Aboud; Hwee-Yong Yap; Laura Esparza; George R. Blumenschein; Gabriel Hor 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 2 views

Combination teletherapy and iridium impl

Combination teletherapy and iridium implantation in the treatment of locally advanced breast cancer

✍ Stephen J. Alderman 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

Castration in the treatment of operable

Castration in the treatment of operable breast cancer

✍ Edward F. Lewison 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

I patients with operable breast cancer, is it wise to perform prophylactic castration as an adjunct to mastectomy or is it wiser to perform therapeutic castration at a later date, if needed, for the treatment of metastasesP This is, indeed, the physician's dilemma! Is the wisdom of prophylactic cast